BiotechTube
Home/Ensysce Biosciences/Jeffrey Millard, PhD
JM

Jeffrey Millard, PhD

Chief Operating Officer

Ensysce Biosciences

Therapeutic Areas

Pain ManagementOpioid Use Disorder

Ensysce Biosciences Pipeline

DrugIndicationPhase
PF614Management of severe painPhase 2
PF614-MPARManagement of severe pain with overdose protectionPhase 2
PF650Management of severe pain in opioid-tolerant patientsPhase 1

Leadership Team at Ensysce Biosciences

DL
D. Lynn Kirkpatrick, PhD
Chief Executive Officer
DH
Dave Humphrey
Chief Financial Officer
BS
Bill Schmidt, PhD
Chief Medical Officer
GB
Geoff Birkett
Chief Commercial Officer
LP
Linda Pestano, PhD
Chief Development Officer
View full Ensysce Biosciences profile